Obesity Drugs Are Scaling Fast Apr 22, 2026 Innovation and policy support could more than double sales of GLP-1 medications by 2035
Tablets In addition to injectable forms, semaglutide is also available as oral tablets
GLP-1s, first approved for type 2 diabetes in 2005, lower blood glucose, help avoid fatty liver disease, and help with obesity-related problems such as knee pain, sleep apnea, and gastroesophageal reflux
For a 5 mg semaglutide vial, 0.5-1 mL of bacteriostatic water creates a concentrated solution appropriate for the tiny weekly doses
Your prescriber does not need to write a new prescription if the original was for "semaglutide" generically
Andrew introduces a paper examining how our beliefs about the medications we take influence their biological effects, distinguishing the belief effect from a placebo effect and highlighting its exciting implications for the future